Hematopoietic prostaglandin (PG) D synthase (PGDS)is the first identified vertebrate ortholog in the Sigma class of the glutathione S-transferase (GST) family and catalyzes both isomerization of PGH 2 to PGD 2 and conjugation of glutathione to 1-chloro-2,4-dinitrobenzene. We introduced site-directed mutations of
199, which are presumed to participate in catalysis or PGH 2 substrate binding based on the crystallographic structure. Mutants were analyzed in terms of structure, GST and PGDS activities, and activation of the glutathione thiol group. Of all the mutants, only Y8F, W104I, K112E, and L199F showed minor but substantial differences in their far-UV circular dichroism spectra from the wild-type enzyme. Y8F, R14K/E, and W104I were completely inactive. C156L/Y selectively lost only PGDS activity. K112E reduced GST activity slightly and PGDS activity markedly, whereas K198E caused a selective decrease in PGDS activity and K m for glutathione and PGH 2 in the PGDS reaction. No significant changes were observed in the catalytic activities of Y152F and L199F, although their K m for glutathione was increased. Using 5,5-dithiobis(2-nitrobenzoic acid) as an SH-selective agent, we found that only Y8F and R14E/K did not accelerate the reactivity of the glutathione thiol group under the low reactivity condition of pH 5.0.
Prostaglandin (PG)1 D synthase (PGDS) is the key enzyme responsible for the formation of PGD 2 and its additional metabolites, the J series of PGs; and these prostanoids exhibit a variety of pharmacological activities and are involved in a number of physiological processes (1). For example, PGD 2 induces vasodilation and bronchoconstriction (2, 3); inhibits platelet aggregation (4); regulates body temperature (5, 6), hormone release (7), and nociception (8); and promotes sleep (9). Furthermore, ⌬ 12 -PGJ 2 inhibits the growth of various tumor cell lines (10), and 15-deoxy-⌬ 12,14 -PGJ 2 is an endogenous ligand for a nuclear receptor, peroxisome proliferator-activated receptor ␥ (11, 12).Two distinct types of PGDS have been isolated and characterized biochemically and immunologically; one is GSHdependent or hematopoietic PGDS (13,14), and the other is GSH-independent or lipocalin-type PGDS (15). Hematopoietic PGDS expressed in antigen-presenting, Kupffer, dendritic, Langerhans (16), megakaryoblastic (17), and mast (18, 19) cells of various organs is involved in the production of PGD 2 as an allergic and inflammatory mediator. In addition, it was characterized as a member of the glutathione S-transferase (GST) gene family (20), whose members are known to catalyze the conjugation of GSH to an electrophilic substrate (21).Recently, we cloned the cDNA for rat hematopoietic PGDS, crystallized the recombinant enzyme, and determined by x-ray crystallography the three-dimensional structure of the enzyme complexed with GSH (22). The deduced amino acid sequence and the tertiary structure of hematopoietic PGDS classified the enzyme as a member of the Sigma class of GSTs. The enzyme isomerizes PGH 2 to PGD 2 sele...